Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

Effect of Transfer Energy Capacitive and Resistive Therapy on Palmar Fibromatosis

The objective of the present study is to explore the effect of Transfer Energy Capacitive and Resistive Therapy (TECAR) therapy on pain, range of motion (ROM) and hand function in dupuytren's contracture patients (palmar fibromatosis).

Dupuytren contracture is a benign, progressive disease of the palmar fascia which results in shortening, thickening, and fibrosis of the fascia and aponeurosis of the palm driven by myofibroblastic proliferation.

TECAR therapy is considered a special form of energy that uses frequencies between 300 KHz and 1 MHz and is characterized as a non-invasive high-frequency energy that awakens the body's natural ability to self-regenerate.

The TECAR therapy can work in two modes of electric charge transfer: capacitive and resistive mode. The reactions produced by the capacitive system through the capacitive electrode are focused on tissues with higher electrolyte content, such as soft tissues and muscles, as opposed to the resistive system that focuses on larger and more resistant tissues such as tendons, bones and articulations. With these two modes of energy transfer, the therapy allows an increase in vasodilation, oxygenation, increase in microcirculation and increase in internal temperature. So, this study aimed to to explore the effect of Transfer Energy Capacitive and Resistive Therapy (TECAR) therapy on pain, range of motion (ROM) and hand function in dupuytren's contracture patients (palmar fibromatosis).

Inclusion Criteria:

• Ages of patients will be ranged from 40 to 70 years.
• Presence of palpable cords and/or digital contracture ≥ 20° at the metacarpophalengeal joint or Proximal interphalengeal joint joints .
• Clinical diagnosis confirmed by a hand surgeon or relevant specialist.
• All patients will enter the study having their informed consent

Exclusion Criteria:

• Patient with severe contracture >30° or multiple digit involvement requiring surger.
• History of surgical release (fasciotomy, fasciectomy) or collagenase injection in the affected hand.
• Presence of infection, ulceration, or skin lesions on the treatment area.
• Presence of pacemakers, metal implants, or other electronic implants in the treatment area.
• Active cancer or tumor in the treatment region.
• Pregnancy.
• Conditions such as stroke, Parkinson's disease, or rheumatoid arthritis that may confound results.
• Cognitive impairment, psychiatric illness, or other barriers to protocol adherence